Industries / Life Sciences & Healthcare
Life Sciences & Healthcare
Kenya's healthcare sector is undergoing transformation. UHC implementation, expanding private provision, pharmaceutical manufacturing growth, and increasing clinical research create opportunity and legal complexity.
Your Business, Our Solutions.
Overview
Kenya's healthcare sector is undergoing transformation. UHC implementation, expanding private provision, pharmaceutical manufacturing growth, and increasing clinical research create opportunity and legal complexity.
We advise healthcare providers, pharma and biotech companies, medical device suppliers, and healthtech businesses on regulatory compliance, corporate structuring, IP, employment, data protection, and disputes.
Most matters cross two or three of these.
Describe the situation in your own words. We will tell you what it actually involves, which services it touches, and what it will cost, before you commit to anything.
Why clients instruct us for life sciences & healthcare
Four commitments specific to this practice.
The regulatory web, navigated whole
Pharmacy and Poisons Board, the Anti-Counterfeit Authority and health data obligations, which overlap rather than divide cleanly.
Pharmaceutical IP, including what Kenya lacks
We advise on patent strategy in a jurisdiction with no data exclusivity regime, where ordinary Industrial Property Act rules decide outcomes.
Clinical research and health data
Trial agreements and DPA 2019 compliance for sensitive personal data.
Device and product market entry
Registration work for manufacturers and distributors entering the Kenyan market.
Latest Insights
Discover more
Financial ServicesLegal Considerations for Health Insurers and Insurtech Platforms After the SHIF TransitionHealth insurers and insurtech platforms operating in Kenya are often unsure exactly how the Social Health Insurance Fund…28 Aug 2026
Regulatory & ComplianceSEZ or EPZ? Choosing the Right Regime for Pharmaceutical Manufacturing in KenyaChoosing SEZ or EPZ is the first structural decision a pharmaceutical manufacturer setting up production in Kenya has…28 Aug 2026
Corporate & CommercialLegal Due Diligence for Private Equity Investing in Kenyan Hospital GroupsA private equity fund evaluating a Kenyan hospital group is buying more than beds and a brand. It…28 Aug 2026
Regulatory & ComplianceFrom NHIF to SHA: A Legal Transition Guide for Private Hospitals and ProvidersThe National Hospital Insurance Fund stopped being the vehicle for public health cover on 1 October 2024, replaced…28 Aug 2026
Corporate & CommercialA Foreign Pharmaceutical Company’s Guide to Market Entry in KenyaA pharmaceutical company market entry into Kenya, whether by a foreign pharmaceutical business or a healthtech company, faces…28 Aug 2026
Intellectual PropertyCounterfeit Medicines: PPB, the Anti-Counterfeit Authority, and Kenya’s Enforcement GapsCounterfeit medicines in Kenya are policed by two separate agencies whose mandates overlap rather than divide cleanly, and…29 Jul 2026
Intellectual PropertyPatent Protection for Pharmaceuticals: Why Kenya Has No Data Exclusivity RegimePatent protection for pharmaceuticals rests on ordinary Industrial Property Act rules in Kenya, and that word "ordinary" matters…29 Jul 2026
Regulatory & ComplianceKenya’s Strategic Goods Control Bill: Export Controls on Dual-Use ItemsKenya's Strategic Goods Control Bill is currently before the National Assembly, tabled on 7 April 2026 by Majority…4 Jul 2026Get in touch
Tell us what you are working on. You will get a clear view of what the matter involves and what it costs before you commit to anything.
- &Your consultation fee is credited in full against your engagement fee
- &Scope, approach and fee confirmed in writing before work begins
- &Our full fee schedule is published online
- &Nextgen Mall, 5th Floor Suite 6, Mombasa Road, Nairobi